source
- FDA warns of secondary cancers linked to tazemetostat in follicular lymphoma and epithelioid sarcomaThe FDA issued an alert after the voluntary withdrawal of tazemetostat indications for follicular lymphoma and epithelioid sarcoma, emphasizing the drug's association with secondary primary maligna…
- Bayer signals cautious yet aggressive push into pharma acquisitions after five-year pauseBayer's CEO Bill Anderson told investors on the first-quarter earnings call that the company is ready to re-enter the pharmaceutical merger-and-acquisition market after a five-year hiatus. He emph…Endpoints · 4mo agoDealPositive